In epidemiological studies of type 2 diabetes, it has been consistently observed that the addition of insulin to the treatment regimen or the intensification of insulin treatment may significantly improve the glucose control, but at the same time it had to pay the price of hyperinsulinemia, which may lead to insulin-induced metabolic stress in the heart. This evidence concerns the gene INS and type 2 diabetes mellitus.